Showing results (431-440 of 588) with videos related to
Sort By:
Pageof 59
Archiv Der Pharmazie|October 11, 2023
Structural modification of naturally occurring phenolics as a strategy for developing cytotoxic molecules towards cancer cellsPedro Olim, Renato B Pereira, Maria José G Fernandes, et al.Nanotechnology|February 14, 2014
Nanocrystalline cellulose applied simultaneously as the gate dielectric and the substrate in flexible field effect transistorsD Gaspar, S N Fernandes, A G de Oliveira, et al.Journal of Dental Research|June 27, 2006
Omega-3 fatty acid effect on alveolar bone loss in ratsL Kesavalu, B Vasudevan, B Raghu, et al.Frontiers in Bioengineering and Biotechnology|March 3, 2020
Maturation of Human Pluripotent Stem Cell-Derived Cerebellar Neurons in the Absence of Co-cultureTeresa P Silva, Evguenia P Bekman, Tiago G Fernandes, et al.Neurobiology of Aging|June 29, 2025
Explaining tip-of-the-tongue experiences in older adults: The role of brain-based and cardiorespiratory fitness factorsFoyzul Rahman, Kamen A Tsvetanov, Jack Feron, et al.Immunopharmacology and Immunotoxicology|May 13, 2026
The anti-inflammatory activity and toxicological safety of synthetic chalcone derivatives in preclinical trialsPaula G F de Oliveira, Tainá L Lubschinski, Octavio L G Fernandes, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 12, 1998
Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulinB D Schaan, C Y Maeda, H B Timm, et al.Musculoskeletal Care|July 27, 2025
'Removing a Blindfold': Perspectives of Physical Therapists After Completing the PEAK-Portuguese E-Learning CourseHugo Jario Almeida Silva, Bruno T Saragiotto, Lívia G Fernandes, et al.International Journal of Molecular Sciences|April 12, 2022
Eugenol β-Amino/β-Alkoxy Alcohols with Selective Anticancer ActivityCláudia Teixeira, Renato B Pereira, Nuno F S Pinto, et al.Pulmonology|April 13, 2022
Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitorsM Serino, C Freitas, M Martins, et al.Pageof 59